The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.
In a study published in NEJM Catalyst, Mayo Clinic researchers have demonstrated that chemotherapy can be safely delivered in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results